基质反应能否预测癌症致死性？
Can stroma reaction predict cancer lethality?
机构信息
Authors' Affiliations: Departments of Medicine, Surgery, Biomedical Sciences, and Biostatistics and Bioinformatics Center, Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California.
出版信息
Clin Cancer Res. 2013 Sep 15;19(18):4905-7. doi: 10.1158/1078-0432.CCR-13-1694. Epub 2013 Sep 5.
Abstract
Stromal features in carcinomas may provide a relatively consistent means to stratify patients afflicted with solid tumors. Stroma-derived transcriptome signatures can now be used to make predictions about patient survival, suggesting the potential for their clinical application in precision medicine to predict disease progression and emergence of therapeutic resistance.
摘要
肿瘤中的基质特征可能为分层患有实体瘤的患者提供一种相对一致的手段。现在可以使用源自基质的转录组特征来预测患者的生存情况，这表明它们有可能在精准医疗中用于临床应用，以预测疾病进展和治疗耐药性的出现。
相似文献
1
Can stroma reaction predict cancer lethality?基质反应能否预测癌症致死性？
Clin Cancer Res. 2013 Sep 15;19(18):4905-7. doi: 10.1158/1078-0432.CCR-13-1694. Epub 2013 Sep 5.
2
Asporin is a stromally expressed marker associated with prostate cancer progression.阿朴脂蛋白是一种与前列腺癌进展相关的基质表达标志物。
Br J Cancer. 2017 Mar 14;116(6):775-784. doi: 10.1038/bjc.2017.15. Epub 2017 Feb 2.
3
Stromal responses among common carcinomas correlated with clinicopathologic features.常见癌间质反应与临床病理特征的相关性。
Clin Cancer Res. 2013 Sep 15;19(18):5127-35. doi: 10.1158/1078-0432.CCR-12-3127. Epub 2013 Jun 26.
4
Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers.将患者来源的异种移植模型的全转录组分析作为一种识别肿瘤和基质特异性生物标志物的工具。
Oncotarget. 2016 Apr 12;7(15):20773-87. doi: 10.18632/oncotarget.8014.
5
Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy.直肠癌放化疗后基质CD26表达的预后相关性
Int J Clin Oncol. 2016 Apr;21(2):350-358. doi: 10.1007/s10147-015-0902-8. Epub 2015 Sep 14.
6
The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian Cancer.基质混合对浆液性卵巢癌分子亚型和预后基因特征的影响。
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):509-519. doi: 10.1158/1055-9965.EPI-18-1359. Epub 2019 Dec 23.
7
Fibrous stroma is associated with poorer prognosis in lung squamous cell carcinoma patients.纤维基质与肺鳞癌患者预后不良相关。
J Thorac Oncol. 2011 Sep;6(9):1460-7. doi: 10.1097/JTO.0b013e318229189d.
8
Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome.乳腺癌中基质 Cav-1 的表达。与早期肿瘤复发和临床结果的相关性。
Pathol Oncol Res. 2012 Apr;18(2):459-69. doi: 10.1007/s12253-011-9469-5. Epub 2011 Nov 7.
9
Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases.原发性结直肠癌及其转移灶肿瘤相关基质中血管生成因子的肿瘤部位依赖性表达谱。
Br J Cancer. 2014 Jan 21;110(2):441-9. doi: 10.1038/bjc.2013.745. Epub 2013 Nov 28.
10
Development of a predictive model for stromal content in prostate cancer samples to improve signature performance.开发用于预测前列腺癌样本中基质含量的预测模型，以提高特征性能。
J Pathol. 2019 Dec;249(4):411-424. doi: 10.1002/path.5315. Epub 2019 Oct 16.
引用本文的文献
1
Extracellular Mechanical Stimuli Alters the Metastatic Progression of Prostate Cancer Cells within 3D Tissue Matrix.细胞外机械刺激改变三维组织基质中前列腺癌细胞的转移进程。
Bioengineering (Basel). 2023 Oct 31;10(11):1271. doi: 10.3390/bioengineering10111271.
2
Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma.计算肿瘤基质反应评估在高级别浆液性卵巢癌中带来了与预后相关的新纤维化和分子特征发现。
Front Med (Lausanne). 2022 Sep 7;9:994467. doi: 10.3389/fmed.2022.994467. eCollection 2022.
3
Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.鉴定与结直肠癌肿瘤微环境相关的预后免疫相关基因特征。
BMC Cancer. 2021 Aug 8;21(1):905. doi: 10.1186/s12885-021-08629-3.
4
Tumor proportion in colon cancer: results from a semiautomatic image analysis approach.结肠癌的肿瘤比例：基于半自动图像分析方法的结果。
Virchows Arch. 2020 Aug;477(2):185-193. doi: 10.1007/s00428-020-02764-1. Epub 2020 Feb 19.
5
CD73 on cancer-associated fibroblasts enhanced by the A-mediated feedforward circuit enforces an immune checkpoint.肿瘤相关成纤维细胞中的 CD73 受 A 介导的正反馈回路增强，从而加强了免疫检查点。
Nat Commun. 2020 Jan 24;11(1):515. doi: 10.1038/s41467-019-14060-x.
6
Association of the tumour stroma percentage in the preoperative biopsies with lymph node metastasis in colorectal cancer.术前活检中肿瘤间质百分比与结直肠癌淋巴结转移的相关性。
Br J Cancer. 2020 Feb;122(3):388-396. doi: 10.1038/s41416-019-0671-7. Epub 2019 Dec 2.
7
An isoform of AIF1 involved in breast cancer.一种参与乳腺癌的AIF1亚型。
Cancer Cell Int. 2018 Oct 22;18:167. doi: 10.1186/s12935-018-0663-3. eCollection 2018.
8
Profiling Prostate Cancer Therapeutic Resistance.前列腺癌治疗抵抗的特征分析。
Int J Mol Sci. 2018 Mar 19;19(3):904. doi: 10.3390/ijms19030904.
9
Reversion of epithelial-mesenchymal transition by a novel agent DZ-50 via IGF binding protein-3 in prostate cancer cells.新型药物DZ-50通过胰岛素样生长因子结合蛋白-3逆转前列腺癌细胞中的上皮-间质转化
Oncotarget. 2017 Jul 28;8(45):78507-78519. doi: 10.18632/oncotarget.19659. eCollection 2017 Oct 3.
10
The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer.浸润性导管癌患者中肿瘤芽生、肿瘤微环境与生存之间的关系。
Br J Cancer. 2015 Sep 29;113(7):1066-74. doi: 10.1038/bjc.2015.287. Epub 2015 Aug 11.
本文引用的文献
1
Stromal responses among common carcinomas correlated with clinicopathologic features.常见癌间质反应与临床病理特征的相关性。
Clin Cancer Res. 2013 Sep 15;19(18):5127-35. doi: 10.1158/1078-0432.CCR-12-3127. Epub 2013 Jun 26.
2
Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment.乳腺癌微环境中 CD10+基质细胞的特征和临床评估。
Clin Cancer Res. 2012 Feb 15;18(4):1004-14. doi: 10.1158/1078-0432.CCR-11-0383. Epub 2012 Jan 10.
3
Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer.多重量子点标记激活的 c-Met 信号在去势抵抗性人前列腺癌中的作用。
PLoS One. 2011;6(12):e28670. doi: 10.1371/journal.pone.0028670. Epub 2011 Dec 21.
4
Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.三维共培养中前列腺癌与骨基质的共同进化：对癌症生长和转移的影响
Cancer Res. 2008 Dec 1;68(23):9996-10003. doi: 10.1158/0008-5472.CAN-08-2492.
5
The fibromatosis signature defines a robust stromal response in breast carcinoma.纤维瘤病特征定义了乳腺癌中一种强烈的基质反应。
Lab Invest. 2008 Jun;88(6):591-601. doi: 10.1038/labinvest.2008.31. Epub 2008 Apr 14.
6
Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis.响应上皮肿瘤发生，p53缺失导致基质间充质的选择性进化。
Cell. 2005 Dec 16;123(6):1001-11. doi: 10.1016/j.cell.2005.09.030.
7
Determination of stromal signatures in breast carcinoma.乳腺癌中基质特征的测定。
PLoS Biol. 2005 Jun;3(6):e187. doi: 10.1371/journal.pbio.0030187. Epub 2005 May 10.
8
Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer.反应性基质作为前列腺癌无生化复发的预测指标
Clin Cancer Res. 2003 Oct 15;9(13):4792-801.
9
Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenicity of prostate epithelial cells.成纤维细胞生长因子受体2限制而受体1加速前列腺上皮细胞的致瘤性。
Cancer Res. 1997 Dec 1;57(23):5369-78.
10
Tissue interactions and prostatic growth: II. Morphological and biochemical characterization of adult mouse prostatic hyperplasia induced by fetal urogenital sinus implants.组织相互作用与前列腺生长：II. 胎儿泌尿生殖窦植入诱导成年小鼠前列腺增生的形态学和生化特征
Prostate. 1985;6(3):241-53. doi: 10.1002/pros.2990060304.
Zotero 插件